ENTRY       D11372                      Drug
NAME        Duvortuxizumab (USAN)
FORMULA     C4850H7485N1305O1487S35
EXACT_MASS  108921.0425
MOL_WEIGHT  108988.4522
SEQUENCE    (A chain)
            ENVLTQSPAT LSVTPGEKAT ITCRASQSVS YMHWYQQKPG QAPRLLIYDA SNRASGVPSR
            FSGSGSGTDH TLTISSLEAE DAATYYCFQG SVYPFTFGQG TKLEIKGGGS GGGGEVQLVE
            SGGGLVQPGG SLRLSCAASG FTFSTYAMNW VRQAPGKGLE WVGRIRSKYN NYATYYADSV
            KGRFTISRDD SKNSLYLQMN SLKTEDTAVY YCVRHGNFGN SYVSWFAYWG QGTLVTVSSA
            STKGEVAACE KEVAALEKEV AALEKEVAAL EKGGGDKTHT CPPCPAPEAA GGPSVFLFPP
            KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV
            LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR EEMTKNQVSL
            WCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC
            SVMHEALHNH YTQKSLSLSP GK
            (B chain)
            QAVVTQEPSL TVSPGGTVTL TCRSSTGAVT TSNYANWVQQ KPGQAPRGLI GGTNKRAPWT
            PARFSGSLLG GKAALTITGA QAEDEADYYC ALWYSNLWVF GGGTKLTVLG GGGSGGGGQV
            TLRESGPALV KPTQTLTLTC TFSGFSLSTS GMGVGWIRQP PGKALEWLAH IWWDDDKRYN
            PALKSRLTIS KDTSKNQVFL TMTNMDPVDT ATYYCARMEL WSYYFDYWGQ GTTVTVSSAS
            TKGKVAACKE KVAALKEKVA ALKEKVAALK E
            (C chain)
            DKTHTCPPCP APEAAGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
            GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
            GQPREPQVYT LPPSREEMTK NQVSLSCAVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
            DGSFFLVSKL TVDKSRWQQG NVFSCSVMHE ALHNRYTQKS LSLSPG
            (Disulfide bridge: A23-A87, A136-A212, A249-B248, A281-C6, A284-C9, A316-A376, A422-A481, B22-B90, B140-B215, C41-C101, C147-C205)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of B-cell malignancies
TARGET      CD19 [HSA:930] [KO:K06465]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04640(916+930)  Hematopoietic cell lineage
            hsa04660(916)  T cell receptor signaling pathway
            hsa04662(930)  B cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11372  Duvortuxizumab (USAN)
                CD19
                 D11372  Duvortuxizumab (USAN)
DBLINKS     CAS: 1831098-91-9
            PubChem: 384585350
///
